Skip to main content
Earnings Labs
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR)

NASDAQ·Healthcare·Biotechnology

$20.89

+2.65%

Mkt Cap $3.25B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (17 analysts)

$108.67

Range $70.00 – $145.00

Implied Upside

+420.2%

Consensus $108.67 vs current $20.89